Detalles de la búsqueda
1.
The role of high-risk HPV testing in cervical cancer surveillance.
Gynecol Oncol
; 164(2): 357-361, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34836678
2.
Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal interval tumor reductive surgery for advanced ovarian cancer.
Gynecol Oncol
; 156(3): 530-534, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31937450
3.
Measurements of adiposity as prognostic biomarkers for survival with anti-angiogenic treatment in epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group ancillary data analysis of GOG 218.
Gynecol Oncol
; 155(1): 69-74, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31409486
4.
A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852).
Ann Oncol
; 28(3): 505-511, 2017 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27998970
5.
Outcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian cancer.
Gynecol Oncol
; 129(1): 103-6, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23369942
6.
Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer.
Gynecol Oncol
; 124(2): 221-4, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22055764
7.
Sustained progression-free survival with weekly paclitaxel and bevacizumab in recurrent ovarian cancer.
Gynecol Oncol
; 115(3): 396-400, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19804901
8.
Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab.
Gynecol Oncol Rep
; 30: 100502, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31720357
9.
Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance.
Int J Gynecol Cancer
; 18(3): 487-91, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-17692090
Resultados
1 -
9
de 9
1
Próxima >
>>